Innovation and the pharmaceutical industry
Subtitle: critical reflections on the virtues of profit
By: edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.
Contributors: Engelhardt, H. Tristram 1941-; Garrett, Jeremy R.
Series: Trends and conflicts
Publisher: M & M Scrivener Press
Published: 2008
Place of publication: Salem, MA
Language: eng
Number of pages: 245
ISBN-13: 9780980209440
Subjects: Drug Industry -- economics -- United States; Pharmaceutical industry; Drug development; Medical innovations; Drug Industry -- ethics -- United States; Health Policy -- United States; Pharmaceutical Preparations -- economics -- United States
Notes: Includes bibliographical references and index.
Table of contents: title: Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett; title: The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr; title: Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi; title: Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang; title: Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor; title: Pharmaceutical advertising and patient autonomy / Andrew I. Cohen; title: Does America have a second drug problem? / Richard A. Epstein; title: Global drug innovation in a world of financial finitude: retailing virtue to promote; title: Capital formation and profit / Michael A. Rie; title: Time, money, and the market for drugs / John C. Goodman; title: Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham; title: Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.